Dexcom (DXCM) Other Working Capital Changes (2010 - 2026)

Dexcom (DXCM) has 17 years of Other Working Capital Changes data on file, last reported at -$51.0 million in Q1 2026.

• On a quarterly basis, Other Working Capital Changes fell 209.09% year-over-year to -$51.0 million in Q1 2026; TTM through Mar 2026 was -$19.7 million, a 2914.29% decrease from a year earlier, with the FY2025 full-year figure at $14.8 million, up 155.17% from the prior year.
• Other Working Capital Changes for Q1 2026 stood at -$51.0 million, down from $6.9 million in the prior quarter.
• Over the last five years, Other Working Capital Changes for DXCM reached as high as $97.9 million in Q1 2022 and fell as low as -$51.0 million in Q1 2026.
• Historically, Other Working Capital Changes has averaged $4.8 million across 5 years, with a median of -$6.1 million in 2023.
• Across the five-year window, Other Working Capital Changes surged 1525.81% in 2022 and slumped 1176.92% in 2023, its largest moves.
• Year by year, Other Working Capital Changes stood at $50.4 million in 2022, then slumped by 112.1% to -$6.1 million in 2023, then sank by 31.15% to -$8.0 million in 2024, then jumped by 186.25% to $6.9 million in 2025, then tumbled by 839.13% to -$51.0 million in 2026.
• Per Business Quant data, the three most recent Other Working Capital Changes figures were -$51.0 million in Q1 2026, $6.9 million in Q4 2025, and $2.4 million in Q3 2025.